News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,901 Results
Type
Article (88159)
Company Profile (825)
Press Release (783898)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233343)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18426)
Job Trends (17439)
News (398105)
Policy (39991)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (39)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (371)
Approvals (18623)
Artificial intelligence (674)
Autoimmune disease (188)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (171)
Brain cancer (68)
Breast cancer (692)
Cancer (5295)
Cardiovascular disease (469)
Career advice (3577)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77346)
Collaboration (1934)
Company closure (5)
Compensation (1221)
Complete response letters (79)
COVID-19 (3002)
CRISPR (107)
C-suite (955)
Cystic fibrosis (155)
Data (6608)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7315)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (256)
Earnings (100652)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135736)
Executive appointments (1068)
FDA (21773)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1630)
Gene editing (230)
Generative AI (71)
Gene therapy (710)
GLP-1 (1164)
Government (5475)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (75)
Indications (128)
Infectious disease (3319)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (133)
Intellectual property (268)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (43)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (394)
Machine learning (47)
Management (66)
Manufacturing (914)
MASH (180)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23030)
Metabolic disorders (1467)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3234)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (70)
Obesity (716)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67128)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23901)
Phase 2 (33562)
Phase 3 (25278)
Pipeline (5920)
Policy (355)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (270)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (993)
Real estate (7444)
Recruiting (81)
Regulatory (29304)
Reports (69)
Research institute (2741)
Resumes & cover letters (653)
Rett syndrome (29)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (128)
Vaccines (1188)
Venture capital (101)
Weight loss (493)
Women's health (103)
Worklife (23)
Date
Today (267)
Last 7 days (886)
Last 30 days (3100)
Last 365 days (32841)
2026 (5214)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51674)
Australia (9079)
California (12109)
Canada (3449)
China (1221)
Colorado (511)
Connecticut (526)
Delaware (360)
Europe (118879)
Florida (1798)
Georgia (392)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (569)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1506)
Massachusetts (8877)
Michigan (378)
Minnesota (682)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3248)
New Mexico (33)
New York (3190)
North Carolina (1672)
North Dakota (10)
Northern California (5858)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2414)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4682)
Tennessee (185)
Texas (1904)
United States (43565)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1006)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,901 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
February 26, 2026
·
7 min read
Press Releases
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
February 26, 2026
·
5 min read
Press Releases
Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer
February 26, 2026
·
11 min read
Press Releases
Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
February 26, 2026
·
13 min read
Press Releases
Claritas Rx Unveils Integrated Data and Consent Solution That Drives Higher First Fill Rates and Long-Term Persistence Across Specialty and Rare Brands
February 26, 2026
·
3 min read
Press Releases
FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option
February 26, 2026
·
12 min read
Press Releases
Salma Health Launches Integrated Brain Health Center of Excellence, Ushering in a New Era for Comprehensive Brain Care, Technology, and Research
February 26, 2026
·
7 min read
Press Releases
Northwell’s AI-Powered iNav Speeds Pancreatic Cancer Detection and Care, New Study Shows
February 26, 2026
·
3 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Press Releases
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
February 26, 2026
·
3 min read
1 of 87,291
Next
